Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Other Working Capital Changes (2015 - 2025)

Grifols' (GIFLF) quarterly Other Working Capital Changes came in at $52.9 million in Q4 2016, down 30.42% on a YoY basis from $76.1 million in Q1 2016, and up 22.98% quarter-over-quarter from $43.0 million in Q3 2016.

Analysis

Grifols (GIFLF) Other Working Capital Changes (2015 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Other Working Capital Changes for 7 consecutive years, with $52.9 million the latest figure, recorded in Q4 2016.

  • For the quarter ending Q4 2016, Other Working Capital Changes fell 30.42% year-over-year to $52.9 million; the trailing twelve-month figure through Dec 2016 stood at $259.3 million (down 13.7% YoY), and the FY2025 full-year result was $788.6 million, down 0.81% from the prior year.
  • Other Working Capital Changes improved to $52.9 million in Q4 2016 per GIFLF's latest filing, from $43.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at -$36.1 million in Q4 2025 and bottomed at -$596.2 million in Q4 2022.
  • Historically, Other Working Capital Changes has averaged -$340.9 million across 3 years, with a median of -$390.6 million in 2023.
  • The sharpest annual moves came in 2012 and 2014: Other Working Capital Changes surged 2749.11% in 2012, then plunged 230.37% in 2014.
  • Over 5 years, Other Working Capital Changes stood at $109.7 million in 2012, then sank by 43.15% to $62.4 million in 2013, then rose by 29.48% to $80.7 million in 2014, then retreated by 5.77% to $76.1 million in 2015, then slumped by 30.42% to $52.9 million in 2016.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered $52.9 million, $43.0 million, and $76.1 million for Q4 2016, Q3 2016, and Q4 2015 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -36.09 Mn
Dec 31, 2025 -36.09 Mn
Dec 31, 2023 -390.57 Mn
Dec 31, 2023 -390.57 Mn
Dec 31, 2022 -596.18 Mn
Dec 31, 2022 -596.18 Mn
Dec 31, 2016 53.27 Mn
Dec 31, 2016 53.27 Mn
Sep 30, 2016 -496.93 Mn
Sep 30, 2016 -496.93 Mn
Dec 31, 2015 -282.48 Mn
Dec 31, 2015 -282.48 Mn
Sep 30, 2015 35.08 Mn
Sep 30, 2015 35.08 Mn